|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2000-5-9
|
|
pubmed:abstractText |
Interleukin-2 (IL-2) and sodium butyrate allow rats to be cured of peritoneal carcinomatosis from colon cancer. We performed a phase I trial of IL-2 and high-dose arginine butyrate (ArgB) in patients with advanced metastatic colorectal cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0340-7004
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
56-61
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10782866-Adjuvants, Immunologic,
pubmed-meshheading:10782866-Aged,
pubmed-meshheading:10782866-Animals,
pubmed-meshheading:10782866-Arginine,
pubmed-meshheading:10782866-Colorectal Neoplasms,
pubmed-meshheading:10782866-Female,
pubmed-meshheading:10782866-Humans,
pubmed-meshheading:10782866-Infusions, Intravenous,
pubmed-meshheading:10782866-Injections, Subcutaneous,
pubmed-meshheading:10782866-Interleukin-2,
pubmed-meshheading:10782866-Male,
pubmed-meshheading:10782866-Middle Aged,
pubmed-meshheading:10782866-Neoplasm Metastasis,
pubmed-meshheading:10782866-Rats,
pubmed-meshheading:10782866-Treatment Outcome
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Phase I trial of interleukin-2 and high-dose arginine butyrate in metastatic colorectal cancer.
|
|
pubmed:affiliation |
Centre René Gauducheau, CRLCC Nantes-Atlantique, Saint-Herblain, France. s-scientifique@nantes.fnclcc.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase I
|
